Chaft JE, Oezkan F, Kris MG, Bunn PA, et al. Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nat Med 2023 Oct 10. doi: 10.1038/s41591-023-02627.
PMID: 37816821